AGP Picks
View all

Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

Press releases published on July 29, 2026

RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
Publication of Prospectus
XORTX Appoints New Director
Surge Copper Announces Board Renewal and Director Nominees for 2026 Annual General Meeting
Morocco Strategic Minerals Reports 14.88% Copper and 696 g/t Silver at Ouneine and up to 4.16 g/t Gold at Aït Zekri
Fortrea Reports Second Quarter 2026 Results
MEXC and CoinGecko Report: CEX TradFi Volume Surges Over 100-Fold as 83.3% of Users Plan to Trade More
Newcore Gold Drilling Intersects 3.67 g/t Gold over 25.3 Metres, at the Enchi Gold Project, Ghana
Titan Secures Strategic Supply Agreement with U.S. Aerospace and Defense Manufacturer
Hudbay Delivers Strong Second Quarter 2026 Results and Improves Cash Cost Guidance

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.